30 May 2022 --- New legislation granting the US Food and Drug Administration (FDA) more control over cosmetic and dietary supplements, has been met with strong opposition across the industry. Amid accusations of increasing powers to the agency, industry organizations are demanding a rewording of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.
.png)
